Our Businesses
Our Company
Share
Back to top
2016 Janssen U.S. Transparency Report
-
The company just released its third annual report and leaders from across Janssen share some top takeaways, including a new initiative to include the list price and potential out-of-pocket costs for its most frequently prescribed medicine.
-
The company just released its second-annual report and we're spotlighting the top takeaways for patients, consumers and healthcare professionals, including a look at how Janssen approaches drug pricing.
-
Group Worldwide Chair Sandi Peterson and Company Group Chairman, Pharmaceuticals, The Americas Jennifer Taubert are honorees once again this year.
-
Jennifer Taubert, Company Group Chairman, Pharmaceuticals, The Americas, explains why Janssen is sharing information around its medication pricing and other business practices.
